Biotechnology Industry Overview
The Biotechnology industry involves the use of living organisms, cells or biological processes to develop and manufacture new products that improve healthcare, agriculture, and industry. It includes genetically modified crop production, new drug development, and advanced diagnostics. Many biotech products are the result of genetic engineering, using cutting-edge technology to manipulate DNA to create new products, such as synthetic insulin or cancer-fighting drugs.
Public Companies in this Industry
Ticker | Company | Market Cap | Country |
---|---|---|---|
068270 | Celltrion Inc | $22t | Korea |
NOVO-B | Novo Nordisk A/S | $2t | Denmark |
4974 | Takara Bio Inc | $208b | Japan |
VRTX | Vertex Pharmaceuticals Inc | $121b | USA |
REGN | Regeneron Pharmaceuticals Inc | $113b | USA |
603392 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd | $107b | China |
300759 | Pharmaron Beijing Co Ltd | $55b | China |
002821 | Asymchem Laboratories Tian Jin Co Ltd | $52b | China |
300957 | Yunnan Botanee Bio-Technology Group Co Ltd | $52b | China |
MRNA | Moderna Inc | $46b | USA |
002252 | Shanghai RAAS Blood Products Co Ltd Class A | $45b | China |
002007 | Hualan Biological EngineeringInc | $45b | China |
SGEN | Seagen Inc | $43b | USA |
1548 | Genscript Biotech Corp | $42b | Hong Kong |
688180 | Shanghai Junshi Biosciences Co Ltd | $41b | China |
603233 | Dashenlin Pharm Grp Co Ltd | $35b | China |
ALNY | Alnylam Pharmaceuticals Inc | $30b | USA |
ARGX | argenx NV ADR | $24b | USA |
BNTX | BioNTech SE | $19.50b | USA |
GMAB | Genmab AS | $16.40b | USA |
BMRN | Biomarin Pharmaceutical Inc | $15.36b | USA |
UCB | UCB SA | $15.04b | Belgium |
BGNE | BeiGene Ltd | $14.89b | USA |
UTHR | United Therapeutics Corporation | $14.75b | USA |
SRPT | Sarepta Therapeutics Inc | $13.90b | USA |
INCY | Incyte Corporation | $13.52b | USA |
KRTX | Karuna Therapeutics Inc | $11.38b | USA |
RPRX | Royalty Pharma plc | $11.33b | USA |
TECH | Bio-Techne Corp | $11.27b | USA |
RXDX | Prometheus Biosciences Inc | $9.50b | USA |
INSM | Insmed Inc | $9.14b | USA |
ASND | Ascendis Pharma AS | $7.79b | USA |
LEGN | Legend Biotech Corp | $7.41b | USA |
ROIV | Roivant Sciences Ltd. Common Shares | $7.31b | USA |
EXEL | Exelixis Inc | $7.28b | USA |
HALO | Halozyme Therapeutics Inc | $7.09b | USA |
IMGN | ImmunoGen Inc | $7.06b | USA |
IONS | Ionis Pharmaceuticals Inc | $6.81b | USA |
JAZZ | Jazz Pharmaceuticals plc | $6.56b | USA |
BPMC | Blueprint Medicines Corp | $6.47b | USA |
CERE | Cerevel Therapeutics Holdings Inc | $6.41b | USA |
PCVX | Vaxcyte Inc | $6.04b | USA |
CRBP | Corbus Pharmaceuticals Holdings, Inc | $5.66b | USA |
RETA | Reata Pharmaceuticals Inc | $5.53b | USA |
ISEE | IVERIC bio Inc | $5.48b | USA |
SMMT | Summit Therapeutics PLC | $5.44b | USA |
CYTK | Cytokinetics Inc | $5.16b | USA |
AGEN | Agenus Inc | $5.11b | USA |
MDGL | Madrigal Pharmaceuticals Inc | $5.08b | USA |
KRYS | Krystal Biotech Inc | $4.73b | USA |
APLS | Apellis Pharmaceuticals Inc | $4.27b | USA |
CRSP | Crispr Therapeutics AG | $4.25b | USA |
VKTX | Viking Therapeutics Inc | $4.16b | USA |
RVMD | Revolution Medicines Inc | $4.12b | USA |
BBIO | BridgeBio Pharma Inc | $4.06b | USA |
NUVL | Nuvalent Inc | $3.87b | USA |
NK | NantKwest Inc | $3.71b | USA |
CORT | Corcept Therapeutics Incorporated | $3.51b | USA |
AXSM | Axsome Therapeutics Inc | $3.50b | USA |
IMVT | Immunovant Inc | $3.44b | USA |
MRTX | Mirati Ther | $3.41b | USA |
DNLI | Denali Therapeutics Inc | $3.17b | USA |
CBAY | Cymabay Therapeu | $3.16b | USA |
MNMD | Mind Medicine (MindMed) Inc | $3.03b | USA |
HCM | HUTCHMED (China) Limited | $2.96b | USA |
RNA | Avidity Biosciences Inc | $2.89b | USA |
RARE | Ultragenyx | $2.89b | USA |
ARWR | Arrowhead Pharmaceuticals Inc | $2.81b | USA |
FOLD | Amicus Therapeutics Inc | $2.80b | USA |
IBRX | Immunitybio Inc | $2.75b | USA |
MRUS | Merus BV | $2.74b | USA |
KDNY | Chinook Therapeutics Inc | $2.66b | USA |
ACAD | ACADIA Pharmaceuticals Inc | $2.64b | USA |
ACLX | Arcellx Inc | $2.61b | USA |
TGTX | TG Therapeutics Inc | $2.60b | USA |
MOR | MorphoSys AG | $2.49b | USA |
ADMA | ADMA Biologics Inc | $2.47b | USA |
XENE | Xenon Pharmaceuticals Inc | $2.46b | USA |
CRNX | Crinetics Pharmaceuticals Inc | $2.41b | USA |
AGIO | Agios Pharm | $2.38b | USA |
SWTX | SpringWorks Therapeutics Inc | $2.35b | USA |
RYTM | Rhythm Pharmaceuticals Inc | $2.33b | USA |
PRVB | Provention Bio Inc | $2.28b | USA |
BHVN | Biohaven Pharmaceutical Holding Company Ltd | $2.27b | USA |
DICE | Dice Molecules Holdings LLC | $2.27b | USA |
PTCT | PTC Therapeutics Inc | $2.26b | USA |
VCEL | Vericel Corp Ord | $2.17b | USA |
INO | Inovio Pharmaceuticals Inc | $2.10b | USA |
DYN | Dyne Therapeutics Inc | $1.99b | USA |
NTLA | Intellia Therapeutics Inc | $1.97b | USA |
GERN | Geron Corporation | $1.90b | USA |
BLU | BELLUS Health Inc. | $1.87b | USA |
PRAX | Praxis Precision Medicines Inc | $1.86b | USA |
HRMY | Harmony Biosciences Holdings | $1.80b | USA |
IOVA | Iovance Biotherapeutics Inc | $1.80b | USA |
CLDX | Celldex Therapeutics Inc | $1.75b | USA |
JANX | Janux Therapeutics Inc. Common Stock | $1.74b | USA |
RCKT | Rocket Pharmaceuticals Inc | $1.71b | USA |
PTGX | Protagonist Therapeutics Inc | $1.70b | USA |
IDYA | Ideaya Biosciences Inc | $1.70b | USA |